Recent concerns surrounding hrt

Clinical Endocrinology

Volumn 59, Issue 2, 2003, Pages 145-155

  Armitage, Mary ^a   Nooney, Janet ^b   Evans, Stephen ^c  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^b Medicines Hlthcare Prod R   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; BONE MASS; ESTROGEN THERAPY; FEMALE; FLUSHING; FRACTURE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; OSTEOPOROSIS; OVARY CANCER; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; STROKE; SWEATING; THROMBOEMBOLISM; VASCULAR DISEASE;

ALZHEIMER DISEASE; BREAST NEOPLASMS; CEREBROVASCULAR ACCIDENT; COLONIC NEOPLASMS; CORONARY DISEASE; ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; NEOPLASMS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIAN NEOPLASMS; PROGESTINS; PULMONARY EMBOLISM; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; TREATMENT FAILURE; VENOUS THROMBOSIS;

EID: 0042666830     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01815.x     Document Type: Review

References (49)

1. Beral, V., Banks, E. & Reeves, G. (2002) Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet, 360, 942-944.
2. Beral, V., Banks, E., Reeves, G. & Appleby, P. (1999) Use of hormone replacement therapy and the subsequent risk of cancer. Journal of Epidemiology and Biostatistics, 4, 191-215.
3. Boston Collaborative Drug Surveillance Program. (1974) Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumours in relation to postmenopausal estrogen therapy. New England Journal of Medicine, 290, 15-19.
4. Cauley, J.A., Seeley, D.G., Ensrud, K., Ettinger, B., Black, D. & Cummings, S.R. (1994) Estrogen replacement therapy and fractures in older women. Study of osteoporotic fractures Research Group. Annals of International Medicine, 122, 9-16.
5. Clarke, S.C., Kelleher, J., Lloyd-Jones, H., Slack, M. & Schofield, P.M. (2002) A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT arteriosclerosis study. British Journal of Obstetrics and Gynaecology, 109, 1056-1062.
6. Collaborative Group on Hormonal Factors in Breast Cancer. (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet, 350, 1047-1059.
7. Daly, E., Vessey, M.P., Painter, R. & Hawkins, M.M. (1996) Casecontrol study of venous thromboembolism risk in users of HRT. Lancet, 348, 1027.
8. Dixon, J.M. (2001) Hormone replacement therapy and the breast: we should worry about the increase risk in breast cancer. British Medical Journal, 323, 1381-1382.
9. Fletcher, S.W. & Colditz, G.A. (2002) Failure of estrogen plus progestin therapy for prevention. Journal of the American Medical Association, 288, 366-368.
10. Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., Newby, L.K., Waters, D., Vittinghoff, E. & Wenger, N. (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/progestin Replacement Study Follow-up (HERSII). Journal of the American Medical Association, 288, 49-57.
11. Grady, D., Yaffe, K., Kristof, M., Lin, F., Richards, C. & Barrett-Connor, E. (2002) Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. American Journal of Medicine, 113, 543-548.
12. Grodstein, F., Stampfer, M.J., Goldhaber, S.Z., Manson, J.E., Colditz, G.A., Speizer, F.E., Willett, W.C. & Hennekers, C.H. (1996) Prospective study of exogenous hormones and risk of pulmonary emboli in women. Lancet, 348, 983-987.
13. Grodstein, F., Newcomb, P.A. & Stampfer, M.J. (1999) Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. American Journal of Medicine, 106, 574-582.
14. Heller, R.F. & Jacobs, H.S. (1978) Coronary heart disease in relation to age, sex and the menopause. British Medical Journal, 1, 472-474.
15. Hemminki, E. & McPherson, K. (1997) Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. British Medical Journal, 315, 149-153.
16. Hlatky, M.A., Boothroyd, D., Vittinghoff, E., Sharp, P. & Whooley, M.A. (2002) Quality-of-life and depressive symptoms in post menopausal women receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. Journal of the American Medical Association, 287, 591-597.
17. Hulley, S., Furberg, C., Barrett-Connor, E., Cauley, J., Grady, D., Haskell, W., Knopp, R., Lwery, M., Satterfield, S., Schrott, H., Vittinghoff, E. & Hunninghake, D. (2002) Heart and Estrogen/progestin Replacement Study Follow-up (HERS II). Noncardiovascular disease outcomes during 6.8 years of hormone therapy. Journal of the American Medical Association, 288, 58-66.
18. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B. & Vittinghof, E. (1998) Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in post menopausal women: Heart and Estrogen/progestin Replacement Study (HERS) research group. Journal of the American Medical Association, 280, 605-613.
19. Jick, H., Derby, L.E., Myers, M.W., Vasilakis, C. & Newton, K.M. (1996) Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogen. Lancet, 348, 981-983.
20. Kavanagh, A.M., Mitchell, H. & Giles, G.G. (2000) Hormone replacement therapy and accuracy of mammographic screening. Lancet, 355, 270-274.
21. Keating, N.L., Cleary, P.D., Rossi, A.S., Zaslavsky, A.M. & Ayanian, J.Z. (1999) Use of hormone replacement therapy by postmenopausal women in the United States. Annals of International Medicine, 130, 545-553.
22. Lacey, J.V., Mink, P.J., Lubin, J.H., Sherman, M.E., Troisi, R., Hartge, P., Schatzkin, A. & Schairer, C. (2002) Menopausal hormone replacement therapy and risk of ovarian cancer. Journal of the American Medical Association, 288, 334-341.
23. Lawlor, D.A., Ebrahim, S. & Davey Smith, G. (2002) Role of endogenous oestrogen in aetiology of coronary heart disease: analysis of age related trends in coronary heart disease and breast cancer in England and Wales and Japan. British Medical Journal, 325, 311-312.
24. Lethaby, A., Farquhar, C., Sarkis, A., Roberts, H., Jepson, R. & Barlow, D. (2000) Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Systematic Reviews, 2, CD000402.
25. Lindsay J., Laurin, D., Verreault, R., Herbert, R., Helliwell, B., Hill, G.P. & McDowell, I. (2002) Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Ageing. American Journal of Epidemiology, 156, 445-453.
26. Meade, T.W. & Vickers, M.R. (1999) HRT and cardiovascular disease. Journal of Epidemiology and Biostatistics, 4, 165-190.
27. Medicines Control Agency, Committee on Safety of Medicines. (2002) New product information for hormone replacement therapy. Current Problems in Pharmacovigilance, 28, 1-2.
28. Medicines Control Agency, Safety update on long-term HRT. Current Problems in Pharmacovigilance, 28, 11-12.
29. Michaelsson, K., Baron, J.A., Farahmand, B.Y., Johnell, O., Magnusson, C., Persson, P.G., Perrson, I. & Ljunghall, S. (1988) Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. British Medical Journ, 316, 1858-1863.
30. Mosca, L., Collins, P., Herrington, D.M., Mendelsohn, M.E., Pasternak, R.C., Robertson, R.M., Schenk-Gustaffson, K., Smith, S.C., Taubert, K.A. & Wenger, N.K. (2001) Hormone replacement therapy and cardiovascular disease. A Statement for Healthcare Professionals from the American Heart Association. Circulation, 104, 499-503.
31. Negri, E., Tzonou, A., Beral, V., Lagiou, P., Trichouplos, D., Parazzini, F., Franceschi, S., Booth, M. & La Vecchia, C. (1999) Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European Studies. International Journal of Cancer, 80, 848-851.
32. Noller, K.L. (2002) Estrogen replacement therapy and risk of ovarian cancer. Journal of the American Medical Association, 288, 368-369.
33. Pradhan, A.D., Manson, J.A., Rossouw, J.E., Siscovick, D.S., Mouton, C.P., Rifai, N., Wallace, R.B., Jackson, R.D., Pettinger, M.B. & Ridker, P.M. (2002) Inflammatory biomarkers, hormone replacement therapy and incident coronary heart disease. Prospective analysis from the Women's Health Initiative Observational Study. Journal of the American Medical Association, 288, 980-987.
34. Rapp, S.E., Espeland, M.A., Shumaker, S.A., Henderson, V.W., Brunner, R.L., Manson, J.E., Gass, M.L., Stefanic, M.L., Lane, D.S., Hays, J., Johnson, K.C., Coker, L.H., Dailey, M. & Bowen, D. (2003) Effect of estrogen plus progestin on global cognitive function in postmenopausal women; the Women's Health Initiative Memory Study: a randomised control trial. Journal of the American Medical Association, 289, 2663-2672.
35. Ridker, P.M., Rifai, N., Rose, L., Buring, J.E. & Cook, N.R. (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine, 347, 1557-1565.
36. Riman, T., Dickman, P.W., Nilsson, S., Correia, N., Nordlinder, H., Magnusson, C.M., Weiderpass, E. & Persson, I.R. (2002) Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. Journal of the National Cancer Institute, 94, 497-504.
37. Rodriguez, C., Patel, A.V., Calle, E.E., Jacob, E.J. & Thun, M.J. (2001) Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. Journal of the American Medical Association, 285, 1460-1465.
38. Stevenson, J. (2001) HRT and cardiovascular disease. Essentials of HRT and the Menopause, 1, 1-16.
39. Stevenson, J.C. & Whitehead, M.I. (2002) Hormone replacement therapy. Findings of women's health initiative need not alarm users. British Medical Journal, 325, 113-114.
40. Sturdee, D.W., Barlow, D.H., Ulrich, L.G., Wells, M., Gtdesen, H., Campbell, M., Vessey, M.P., Nielson, B., Anderson, M.C. & Bragg, A.J. (2000) The endometrial response to sequential and continuous combined oestrogen-progestagen replacement therapy. British Journal of Obstetrics and Gynaecology, 107, 1392-1400.
41. Torgerson, D.J. & Bell-Seyer, S.E. (2001) Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomised trials. Journal of the American Medical Association, 285, 2891-2897.
42. Tunstall-Pedoe, H. (1998) Myth and paradox of coronary risk and the menopause. Lancet, 351, 1425-1427.
43. USPSTF (Preventive Services Task Force). (2002) Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. Annals of Internal Medicine, 137, 834-849.
44. Viscoli, C.M., Brass, L.M., Kernan, W.N., Sarrel, P.M., Suissa, S. & Horwitz, R.I. (2001) A clinical trial of estrogen-replacement therapy after ischemic stroke. New England Journal of Medicine, 345, 1243-1249.
45. Weetman, A.P. (2002) Thyroxine treatment in biochemically euthyroid but clinically hypothyroid individuals. Clinical Endocrinology, 57, 25-27.
46. Weiss, N.S. (1980) Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. New England Journal of Medicine, 303, 1195-1198.
47. Wells, M., Sturdee, D.W., Barlow, D.H., Ulrich, L.G., O'Brien, K., Campbell, M., Vessey, M.P. & Bragg, A.J. (2002) Effect on endometrium of long-term treatment with continuous combined oestrogen-progestagen replacement therapy: follow up study. British Medical Journal, 325, 230-242.
48. Writing Group for the Women's Health Initiative Investigators. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association, 288, 321-333.
49. Zandi, P.P., Carlson, M.C., Plassman, B.L., Welsh-Bohmer, K.A., Mayer, L.S., Steffens, D.C. & Breitner, J.C.S. (2002) Hormone replacement therapy and the risk of Alzheimer's disease in older women. The Cache County Study Journal of the American Medical Association, 288, 2123-2129.